Clinical Trials Directory

Trials / Completed

CompletedNCT04660513

Obesity-Related Glycine Deficiency: Investigating a Long-standing Metabolic Paradox Using Bedside and Bench Approaches

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Singapore General Hospital · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers

Summary

Obesity, in addition to causing abnormal glucose and lipid metabolism, is also associated with altered plasma concentrations of multiple amino acids, including increased levels of branched-chain amino acids and decreased levels of glycine. The mechanisms and consequences of obesity- related glycine deficiency are unknown. The overall aim of this project is to comprehensively study glycine metabolic pathways in morbid obesity using stable-isotope tracer techniques in human subjects and validating kinetic findings using a cell model of oxidative stress. This will be a single-centre, observational study. 21 individuals with morbid obesity scheduled for bariatric surgery and 21 non-obese controls will be recruit. They will undergo different study visits and procedures and the human biological materials collected will be analysed for as per aims of the studies. We believe that the glycine metabolic pathways, possibly through the optimization of gluthathione (GSH) synthesis, may provide targets to develop novel therapeutic agents.

Detailed description

Metabolic tracers: 1,2-\[13C2\]-Glycine, 1,2-\[13C2\]-Glycine, 2,3,3,-\[2H3\]-Serine and \[2H5\]-Phenylalanine will be infused for quantification of various pathways associated with glycine metabolism.

Conditions

Interventions

TypeNameDescription
PROCEDUREBariatric surgerySubjects with morbid obesity underwent bariatric surgery

Timeline

Start date
2018-12-08
Primary completion
2020-11-04
Completion
2020-11-04
First posted
2020-12-09
Last updated
2020-12-09

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT04660513. Inclusion in this directory is not an endorsement.